Contribution: Industrial Research Assistance Program – Contributions to Firms
Pharmasilico Technologies Inc.
$122,040.00
Artificial Intelligence (AI)-based system for drug profiling
EF 2020-21 · 2020-05-01
Résumé
The firm is building an artificial intelligence-based system which would be used to computationally profile drug candidates against multiple protein kinases simultaneously. The goal is to dramatically increase the efficiency of drug target screening.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Vancouver|Vancouver, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
766039887
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2021-05-31
Agreement Number
948869
Agreement Start Date
2020-05-01
Agreement Title
Artificial Intelligence (AI)-based system for drug profiling
Agreement Title (French)
Système de profilage de médicaments basé sur l'intelligence artificielle (IA)
Agreement Type
Contribution
Agreement Value
$122,040.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The firm is building an artificial intelligence-based system which would be used to computationally profile drug candidates against multiple protein kinases simultaneously. The goal is to dramatically increase the efficiency of drug target screening.
Description (French)
L'entreprise est en train de mettre au point un système basé sur l'intelligence artificielle qui serait utilisé pour établir par calcul le profil des médicaments candidats contre plusieurs protéines kinases simultanément. L'objectif est d'augmenter considérablement l'efficacité du triage des médicaments cibles.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Quadra
Federal Riding (French)
Vancouver Quadra
Federal Riding Number
59039
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
766039887
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Pharmasilico Technologies Inc.
Recipient Operating Name
Pharmasilico
Recipient Postal Code
V6T 1W5
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2020-2021-Q1-948869
